November 13, 2026 Rezolute Announces Positive Results from the Phase 3 upLIFT Study in Tumor Hyperinsulinism
November 13, 2026 Rezolute Announces Pricing of Approximately $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
November 13, 2026 Club Connect: iCAUR Takes Global Owners from ‘Buying the Same Car’ to ‘Sharing the Same Ecosystem’